Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

Share Price is delayed by 15 minutes
Get Live Data
3.50    0.00 (0.00%)
Bid:
3.00
Ask:
4.00
Spread: 1.00 (33.333%)
Market Cap: £5.77m
NOG Live PriceLast checked at - London Stock Exchange

Intraday Nostrum Oil&gas Share Chart

Further statement in relation to AGM vote

19 Dec 2025 17:02

RNS Number : 3573M
Nostrum Oil & Gas PLC
19 December 2025
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

 

London, 19 December 2025

 

Further statement in relation to AGM vote

 

Nostrum Oil & Gas PLC (LSE: NOG) ("Nostrum" or the "Company"), an independent oil and gas company engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin, notifies that in its 2025 AGM results announcement issued on 30 June 2025, the Company noted that:

· Resolution 2, which proposed to approve the Directors' Remuneration Report, resolution 3, which proposed to reappoint Arfan Khan as a director, resolution 5, which proposed to reappoint Chris Hopkinson as a director and resolution 11, which proposed to permit a notice period of 14 days for general meetings (other than an annual general meeting), were not passed by shareholders; and

 

· Resolution 4, which proposed to reappoint Stephen Whyte as a director and resolution 6, which proposed to reappoint Fiona Paulus as a director, were both duly passed by shareholders but both resolutions received less than 80% of the votes in favour.

 

Following the 2025 AGM, the Board engaged with shareholders in respect of the votes received against these resolutions to better understand these outcomes.

 

The main themes expressed by some shareholders in relation to the votes against mentioned above were that:

 

· Payments made in 2025 under the Company's management incentive plan were considered improper and/or excessive;

 

· It was considered that the determination made on satisfaction of performance conditions for certain payments under the management incentive plan was inappropriate or should have been subject to stakeholders' discretion;

 

· The timing of certain management incentive plan payments was considered inappropriate.

 

Given the feedback received from shareholders to date the Board is reviewing the operation of the management incentive plan. The Company's senior management and Board composition have changed in the period since the AGM, including a new appointment as head of the Remuneration Committee. In its renewed composition, the Board is reviewing and considering suitable amendments to the Remuneration Committee terms of reference, revisions to the management incentive plan and ceasing further grants, releases and/or payouts of awards under the management incentive plan.

 

The Board is committed to continuing its engagement and dialogue with the Company's shareholders on these and other matters to better understand the reasons behind the voting results at the 2025 AGM and to inform future Board discussions, decision-making and actions, and welcomes their feedback.

 

A final summary of the views heard during such consultation will be published in the Company's next annual report.

 

 

LEI: 2138007VWEP4MM3J8B29

 

Further information

For further information please visit www.nostrumoilandgas.com  

 

Further enquiries

Nostrum Oil & Gas PLC

Yelena Zhuravleva, CFO

ir@nog.co.uk

 

TEAM LEWIS

Galyna Kulachek

+ 44 (0) 20 7802 2664

nostrum@teamlewis.com

 

Notifying person

Thomas Hartnett

Company Secretary

 

About Nostrum Oil & Gas

Nostrum Oil & Gas PLC is an independent mixed-asset energy company with world-class gas processing facilities and export hub in north-west Kazakhstan. Its shares are listed on the London Stock Exchange (ticker symbol: NOG). The principal producing asset of Nostrum Oil & Gas PLC is the Chinarevskoye field which is operated by its wholly-owned subsidiary Zhaikmunai LLP, which is the sole holder of the subsoil use rights with respect to the development of the Chinarevskoye field. The Company also owns an 80% interest in Positiv Invest LLP, which holds the subsoil use rights for the "Kamenskoe" and "Kamensko-Teplovsko-Tokarevskoe" areas in the West Kazakhstan region (the Stepnoy Leopard fields).

 

Forward-Looking Statements

Some of the statements in this document are forward-looking. Forward-looking statements include statements regarding the intent, belief and current expectations of the Company or its officers with respect to various matters. When used in this document, the words "expects", "believes", "anticipates", "plans", "may", "will", "should" and similar expressions, and the negatives thereof, are intended to identify forward-looking statements. Such statements are not promises nor guarantees and are subject to risks and uncertainties that could cause actual outcomes to differ materially from those suggested by any such statements.

 

No part of this announcement constitutes, or shall be taken to constitute, an invitation or inducement to invest in the Company or any other entity, and shareholders of the Company are cautioned not to place undue reliance on the forward-looking statements. Save as required by the relevant listing rules and applicable law, the Company does not undertake to update or change any forward-looking statements to reflect events occurring after the date of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FUREAKANFSKSFFA
Date   Source Headline
30th Jun 202312:34 pmRNSResult of AGM
30th Jun 20237:00 amRNS1st Quarter Results
29th Jun 20233:14 pmRNSNotice of Revised Q1 2023 Financial Results Date
27th Jun 20239:37 amRNS2022 Report on Payments to Governments
23rd Jun 20237:00 amRNSCFO Appointment
6th Jun 20234:00 pmRNSNotice of AGM
2nd Jun 20235:58 pmRNSApplication for restoration of listing of Shares
2nd Jun 20238:03 amRNSFull Year Results for the Year Ending 31 Dec 2022
31st May 20238:55 amRNSNotice of Revised 2022 Full Year Results Date
5th May 20232:20 pmRNSSuspension of trading in shares on the AIX
2nd May 20238:54 amRNSSuspension of listing of Shares
28th Apr 20237:00 amRNSOperational Update for Q1 ending 31 March 2023
26th Apr 20234:23 pmRNSTR-1: Notification of major holdings
6th Apr 20237:00 amRNSTR-1: form for notification of major holdings
5th Apr 20237:00 amRNSTR-1: Standard form for notice of major holdings
31st Mar 20238:30 amRNSNostrum Oil & Gas - Capital Markets Day
27th Mar 20237:00 amRNSTR-1: form for notification of major holdings
20th Mar 20238:00 amRNS2023 production guidance
17th Mar 202310:52 amRNSHolding(s) in Company
16th Mar 20233:24 pmRNSDelisting of shares from the official list of KASE
10th Mar 202311:21 amRNSProposed acquisition of Oil & Gas assets
6th Mar 20235:57 pmRNSAppointment of auditors
3rd Mar 202311:49 amRNSNotice of Capital Markets Day
27th Feb 20232:53 pmRNSChanges in Board Committee Composition
24th Feb 20238:46 amRNSStandard form for notification of major holdings
23rd Feb 20235:24 pmRNSHolding(s) in Company
21st Feb 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20238:00 amRNSHolding(s) in Company
15th Feb 20234:40 pmRNSSecond Price Monitoring Extn
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 202311:27 amRNSStandard form for notification of major holdings
15th Feb 20239:11 amRNSHolding(s) in Company
14th Feb 20234:24 pmRNSBoard changes
13th Feb 20238:47 amRNSHolding(s) in Company
10th Feb 20237:52 amRNSAdmission to trading on LSE & total voting rights
9th Feb 20234:58 pmRNSCompletion of the Restructuring
7th Feb 20233:13 pmRNSPublication of a Second Supplementary Prospectus
6th Feb 20234:48 pmRNSRestructuring, Sub-Division & Consolidation Update
30th Jan 20234:48 pmRNSUpdate on Restructuring – Required Licences
27th Jan 20237:00 amRNSOperating Update for FY 2022
20th Jan 20234:10 pmRNSProposed Extension of Scheme Longstop Date
9th Jan 20231:36 pmRNSUpdate on Restructuring – OFSI Licence Approval
6th Dec 20225:09 pmRNSPublication of a Supplementary Prospectus
28th Nov 20224:36 pmRNSPrice Monitoring Extension
25th Nov 20224:36 pmRNSPrice Monitoring Extension
24th Nov 20224:41 pmRNSSecond Price Monitoring Extn
24th Nov 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20224:35 pmRNSPrice Monitoring Extension
22nd Nov 20227:00 amRNSFinancial Results for 3Q and 9M ended 30 Sep 2022
21st Nov 202212:06 pmRNSNotice of Extension of Longstop Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.